Catherine obtained her Veterinary Medicine degree from Lyon French National Veterinary School (1984-88). After realizing her interest was in medical research, Catherine joined the Paris Pasteur Institute to study Acute Promyelocytic leukemia for a PhD (1990-1995). Catherine then studied hematopoietic stem biology and MLL-rearranged leukemias in a biotech company in California (Systemix, 1995-2000).
Catherine was recruited by INSERM (French NIH equivalent) in 2000 to continue her work on MLL-leukemias at St-Louis Hospital in Paris. Catherine came to Duke in 2007 to study CALM-AF10 leukemia with Dan Wechsler. Catherine joined Rory Goodwin’s team in 2018 to pursue research on the biology of spinal metastasis.